Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
2.
J Cell Biochem ; 113(6): 1955-65, 2012 Jun.
Article in English | MEDLINE | ID: mdl-22253051

ABSTRACT

A critical issue in the management of head and neck tumors is radioprotection of the salivary glands. We have investigated whether siRNA-mediated gene knock down of pro-apoptotic mediators can reduce radiation-induced cellular apoptosis in salivary gland cells in vitro. We used novel, pH-responsive nanoparticles to deliver functionally active siRNAs into cultures of salivary gland cells. The nanoparticle molecules are comprised of cationic micelles that electrostatically interact with the siRNA, protecting it from nuclease attack, and also include pH-responsive endosomolytic constituents that promote release of the siRNA into the target cell cytoplasm. Transfection controls with Cy3-tagged siRNA/nanoparticle complexes showed efficiently internalized siRNAs in more than 70% of the submandibular gland cells. We found that introduction of siRNAs specifically targeting the Pkcδ or Bax genes significantly blocked the induction of these pro-apoptotic proteins that normally occurs after radiation in cultured salivary gland cells. Furthermore, the level of cell death from subsequent radiation, as measured by caspase-3, TUNEL, and mitochondrial disruption assays, was significantly decreased. Thus, we have successfully demonstrated that the siRNA/nanoparticle-mediated knock down of pro-apoptotic genes can prevent radiation-induced damage in submandibular gland primary cell cultures.


Subject(s)
Apoptosis/genetics , Nanoconjugates , RNA, Small Interfering/pharmacology , Radiation Injuries/prevention & control , Salivary Glands/cytology , Salivary Glands/radiation effects , Animals , Caspase 3/biosynthesis , Head and Neck Neoplasms/radiotherapy , In Situ Nick-End Labeling , Mice , Mice, Inbred BALB C , Mitochondria/metabolism , Primary Cell Culture , Protein Kinase C-delta/genetics , Protein Kinase C-delta/metabolism , RNA Interference , Radiation-Protective Agents/pharmacology , bcl-2-Associated X Protein/genetics , bcl-2-Associated X Protein/metabolism
3.
Clin Transl Sci ; 4(5): 328-31, 2011 Oct.
Article in English | MEDLINE | ID: mdl-22029803

ABSTRACT

One of the objectives of the Consortium of Institutions with Clinical and Translational Science Awards (CTSAs) is to enhance technology transfer among the CTSAs and with public and private sector partners. Clinical and Translational Sciences Award Intellectual Property (CTSA-IP; http://www.CTSAIP.org) is a web-based, open access IP search tool that aggregates and promotes technologies from member institutions of the National Institutes of Health's (NIH) CTSAs consortium. Its ultimate aim is to stimulate collaborative research activity by encouraging the formation of public-private partnerships with CTSA institutions and the NIH. First launched in 2009, CTSA-IP has grown rapidly and met its first objectives of developing wide member institution participation and site usage. This communication will discuss the strategy employed in the initiative of aggregating IP across institutional boundaries, the promise that lies therein, as well as the challenges encountered and lessons learned in promoting CTSA-wide engagement.


Subject(s)
Academies and Institutes , Awards and Prizes , Intellectual Property , National Institutes of Health (U.S.) , Translational Research, Biomedical , United States
SELECTION OF CITATIONS
SEARCH DETAIL
...